Comparison of the Efficacy of Pharmacology and Non-pharmacological Treatment in Women With Primary Dysmenorrhea.
1 other identifier
interventional
85
1 country
1
Brief Summary
Primary dysmenorrhea is a common problem in women. Women use many treatment methods to deal with primary dysmenorrhea. Therefore, this study aims to find the most effective treatment by determining the effectiveness of conservative and non-conservative treatment in women with primary dysmenorrhea. Another aim of the study is to generalize the use of conservative treatment methods in the treatment of primary dysmenorrhea.On the other hand, it aims to spread the telerehabilitation method, which allows the global Covid 19 outbreak to be maintained remotely online, in the world and in our country.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 10, 2020
CompletedFirst Posted
Study publicly available on registry
December 29, 2020
CompletedStudy Start
First participant enrolled
July 9, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 9, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 10, 2021
CompletedMay 24, 2022
June 1, 2021
5 months
December 10, 2020
May 23, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Demographic Information Form
Participants age, height, weight, educational status, marital status, exercise habits will be recorded. In addition, sociodemographic information, clinical features such as background and family history; Information on menarche age, average cycle duration and menstruation duration, and methods of coping with dysmenorrhea were recorded.
5 minutes
Visual Analogue Scale (VAS)
The Visual Analogue Scale (VAS) is used to convert non-numerical values to digital. The value 0 means I have no pain, 10 means I have unbearable pain. The person marks his pain on this ruler. It measures the intensity of the pain.
2 minutes
McGill Pain Questionnaire
The characteristic of pain felt by the patients during menstruation was evaluated using the McGill Pain Questionnaire-Short Form,With the McGill Melzack Pain Questionnaire, the location of the pain, the feeling it creates in the individual, its relationship with time, its severity and the level of viable pain for the individual are determined. High score indicates high level of pain
5 minutes
Ultrasonography (US)
Ultrasonography is a soft tissue examination method.Its biggest advantages are that it is an easily accessible method and does not contain ionizing radiation. In the evaluation by ultrasonography, dysmenorrhea due to organic problems will be evaluated and excluded by the obstetrician.
5 minutes
Secondary Outcomes (1)
Menstrual Attitude Questionnaire
5 minutes
Study Arms (5)
Focused Pelvic Floor Exercise with Motor ImageryTechnique Group
EXPERIMENTAL5 minute-Meditation Therapy 10 minute-Progressive Relaxation training ( Bernstein-Borkovec Method) 5 min - Breathing Exercises (Diaphragmatic Breathing Exercise, Pursed lip breathing Exercise) 35 min -Motor Imagery Technique Focused Pelvic Floor Exercises-MOPEXE 5 min - Meditation Therapy Twice a week for 60 minutes 12 weeks Participants will be evaluated online at the beginning of the research and at the end of the 12-week program.
Nonsteroidal Anti-Inflammatory Drug(NSAID) Group
ACTIVE COMPARATORNaproxen Sodium 550 mg film-coated tablet prescribed by the physician will be given to patients. During the menstrual period, 1 or 2 times a day will be used depending on the pain of the patient. Treatment time; 12 weeks.
Diosmin Group
OTHERDiosmin (90%) 500 mg film-coated tablets prescribed by the physician will be given to patients. During the menstrual period, 1 or 2 times a day will be used depending on the patient's pain. Treatment time; 12 weeks.
Acupressure Group
EXPERIMENTAL4 acupuncture points will be applied twice a day for 12 weeks. These points are; LI4, CV4, CV6, SP6 .
Control Group
NO INTERVENTIONParticipants will not be treated.
Interventions
This program includes Focused Pelvic Floor with Motor Imagery Technique Group ,Nonsteroidal Anti-Inflammatory Drug Group, Diosmin Group, Acupressure Group (LI-4 (Bilateral), CV-6, CV-4, SP-6 (Bilateral). It is aimed to determine the most effective treatment among these groups.
Eligibility Criteria
You may qualify if:
- Over the age of 18 whose menstrual cycle continues,
- Primary dysmenorrhea was diagnosed by the obstetrician by ultrasonographic evaluation.
- Participants who agree to participate in the study will be included.
- Participants in the diosmin group who were prescribed diosmin by the physician
- Participants in the NSAI group who were prescribed an NSAI by the physician
You may not qualify if:
- Receiving hormone therapy
- Those receiving psychiatric treatment for stress disorder or anxiety
- Intrauterine contraceptive device
- Using birth control pills
- Women diagnosed with secondary dysmenorrhea
- With neurological deficits
- Patients who were not suitable for NSAI and Diosmin treatment by the physician were excluded by the physician and were not included in our study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gizem BOZTAŞ
Istanbul, Kavacık, 34040, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Gizem BOZTAŞ ELVERİŞLİ, Phd
Istanbul Medipol Üniversitesi
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 10, 2020
First Posted
December 29, 2020
Study Start
July 9, 2021
Primary Completion
December 9, 2021
Study Completion
December 10, 2021
Last Updated
May 24, 2022
Record last verified: 2021-06